Clinical
Cardiology | Dermatology | Diabetes | Gastroenterology | Ophthalmology | Psychiatry | Pulmonology | Rheumatology
View All >>
Spotlight
COVID-19 | Epithelial TSLP and Severe Asthma | Sickle Cell Disease | Strains of C. Difficile

Clinical News

View All >>

Aflibercept, Ranbizumab Shown To Improve Visual Acuity in Eyes with CRVO

1 hour ago

By Connor Iapoce

Baseline VA show slight improvement in aflibercept versus ranibizumab treated eyes, (42.5 letters versus 36.9 letters).

Reducing Stress and Racial Disparities in Pediatric Vitiligo

13 hours ago

By Armand Butera

Two study authors speak on providing pediatric patients of color with atopic diseases with greater access to care.

Yamalis Diaz, PhD: The Current State of ADHD Care

15 hours ago

By Kenny Walter

Dr. Yamalis Diaz said ADHD is often under-diagnosed.

Laboratory Markers Aid in Evaluating Atopic Dermatitis

17 hours ago

By Armand Butera

Investigators added that the meaning of each laboratory marker is dependent on the drug that is being used for treatment.

FDA Approves Ruxolitinib for Patients with Chronic Graft-Versus-Host Disease

17 hours ago

By Armand Butera

The drug is approved for adults and pediatric patients 12 years and older after the failure of 1 or 2 lines of systemic therapy.

Crisis Point: Defining the Scope of the Obesity Crisis

Defining the Scope of the Obesity Crisis

HCPLive Crisis Point takes an in-depth look at the obesity crisis, beginning with the process of medical diagnosis and who is impacted the most by the disease.

American Lung Association

ALA Discusses Severe Asthma Biologics with Mario Castro, MD, MPH

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.

Niemann-Pick Disease

The Rare Disease Report Podcast: Niemann-Pick Disease

Listen to an expert discuss the heterogenous, and potentially fatal, lysosomal storage disorder.

Schizophrenia

Coping After COVID: A Troubling Time for Schizophrenia Patients

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

vitiligo research

John E. Harris, MD, PhD: The Current State of Vitiligo and Alopecia Areata Research

The vitiligo expert discusses new tactics and therapeutic options in treating inflammatory skin disorders like vitiligo, alopecia areata, and atopic dermatitis.

Duke Heart

New Heart Failure Data from ESC 2021 with Marat Fudim, MD

Manesh Patel, MD, kicks off his first podcast by discussing HFpEF findings in EMPEROR-Preserved, the GUIDE-HF trial and more with his Duke colleague.

Conference Coverage
View All >>

Tezepelumab Effective in Patients With Severe Uncontrolled Asthma and Nasal Polyps

September 09, 2021

By Armand Butera

In an interview with HCPLive, Dr. Jean-Pierre Llanos-Ackert and Dr. Bill Cook discuss how tezepelumab resulted in improved lung function and an 86% reduction in exacerbation rates in this patient population.

Influenza Vaccination After Myocardial Infarction Lowers Risk of Future CV Events

August 31, 2021

By Connor Iapoce

Data show the outcome of all-cause mortality, MI, or stent thrombosis occurred in 5.3% of patients vaccinated against the flu and 7.2% of patients who were given placebo.

Bertram Pitt, MD: Treating Diabetes, CKD Aggressively with Finerenone

August 31, 2021

By Kevin Kunzmann

Now that the agent shows benefit in mitigating comorbid risks, the expert advocates for more timely diagnoses and treatment initiation.

Hypertension Fixed-Dose Quadpill Treatment Linked to Decrease in Blood Pressure

August 31, 2021

By Connor Iapoce

Investigators observed systolic blood pressure was lower by a rate of 6.9 mm Hg in the intervention group versus the control group.

Video Series
View All >>
Using Crizanlizumab in SCD Treatment
Clinical Implications of Voxelotor in SCD Treatment
Biologics Used in the Treatment of IBD
Surgical Intervention in IBD
Optimizing Therapy for Patients With Atopic Dermatitis
Atopic Dermatitis: Counseling Patients About Their Disease
Support for Patients With Atopic Dermatitis
IBD Treatment: Approach in Moderate- to High-Risk Disease
Using Voxelotor in SCD: Results From HOPE Study
NHLBI Guidelines for Anemia-Related Disease Manifestations
IBD Treatment Options for Patients With Low-Risk Disease
Atopic Dermatitis: Partnering With Patients for Best Outcomes
Atopic Dermatitis: Integrating Newer Therapies into Clinical Practice
Multiorgan Failure in SCD: Renal Complications
Patient Factors to be Considered When Choosing Therapy for IBD
Video Interviews
View All >>
Reducing Stress and Racial Disparities in Pediatric Vitiligo
Laurence Sperling, MD, FACC, FACP, FAHA: Optimizing Cardiovascular Care
The US Pain Foundation Sets September Initiative for Awareness with #PainCounts
Defining the Scope of the Obesity Crisis
Yehuda Handelsman, MD: Organizing a Hybrid Cardiometabolic Meeting in 2021
Kim Smith-Whitley, MD: The Impact of Voxelotor on Pediatric Sickle Cell
Elena Ezhkova, PhD: Evaluating Epigenetic Changes Caused by UV Exposure
Christie Ballantyne, MD: Better Implementing Cardiovascular Research
Kim Smith-Whitley, MD: Voxelotor and Sickle Cell Disease
Christie Ballantyne, MD: Promising Cardiovascular Agents in Diabetes
Kim Smith-Whitley, MD: New Treatment for Children with Sickle Cell Disease
Amar Deshpande, MD: The Future of Multiple Biologics for IBD
Erica P. Gunderson, PhD, MS, MPH: Building More Female Cardiometabolic Data
Javed Butler, MD: Promising Heart Failure Trials and Guideline Limitations
Matthew Budoff, MD: Greater Adoption of SGLT2 Inhibitors and GLP-1 Agonists
Podcasts
View All >>
Yamalis Diaz, PhD: The Current State of ADHD Care
Mario Castro, MD, MPH: Defining Severe Asthma Biomarkers
New Heart Failure Data from ESC 2021 with Marat Fudim, MD
William Chey, MD: Treating Gastrointestinal Diseases With Diet
John E. Harris, MD, PhD: The Current State of Vitiligo and Alopecia Areata Research
Biologic Breakthroughs for Severe Asthma with Dr. Mario Castro
The Rare Disease Report Podcast: Niemann-Pick Disease
Brett King, MD, PhD: The Promise of Janus Kinase Inhibitors
Improving Cancer Care with Precision Medicine and Biomarkers
The Future of Lung Cancer Precision Medicine with Dr. Andrea Mazzocchi
hcplive podcasts